Marianne Kronqvist

Skin test evaluation of genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1: Results obtained with a mix of two recombinant Bet v 1 fragments and recombinant Bet v 1 trimer in a Swedish population before the birch pollen season☆☆☆★

Marianne Kronqvist, O. Zetterström, Eva Johansson et al. · Journal of Allergy and Clinical Immunology · 1999 · 93 citations · Full text

Life Sciences, Dermatology, Immunology +13

Cytokine and Antibody Responses in Birch-Pollen-Allergic Patients Treated with Genetically Modified Derivatives of the Major Birch Pollen Allergen Bet v 1

Guro Gafvelin, Sarah Thunberg, Marianne Kronqvist et al. · International Archives of Allergy and Immunology · 2005 · 85 citations

Life Sciences, Immunology, Pharmacotherapy +17

Evaluation of Specific IgE to the Recombinant Group 2 Mite Allergens Lep d 2 and Tyr p 2 in the Pharmacia CAP System

Eva Johansson, Tove Eriksson, Susanna Olsson et al. · International Archives of Allergy and Immunology · 1999 · 21 citations

Life Sciences, Dermatology, Immunology +17

A Hypoallergenic Derivative of the Major Allergen of the Dust Mite <i>Lepidoglyphus destructor</i>, Lep d 2.6Cys, Induces Less IgE Reactivity and Cellular Response in the Skin than Recombinant Lep d 2

Marianne Kronqvist, Eva Johansson, Paul Whitley et al. · International Archives of Allergy and Immunology · 2001 · 12 citations

Life Sciences, Dermatology, Immunology +15